Journal of Applied Physiology, Vol 57, Issue 3 674-679, Copyright © 1984 by American Physiological Society

ARTICLES

Effects of naloxone on exercise performance

G. D. Surbey, G. M. Andrew, F. W. Cervenko and P. P. Hamilton

This study was designed to investigate the effects of naloxone on athletic performance in humans. Two groups of elite middle-distance runners performed a maximal or a submaximal exercise protocol following the double-blind intravenous injection of either naloxone (0.15 mg X kg body wt-1) or saline. The maximal test (group M) was comprised of a short-duration treadmill run to maximal intensity; the submaximal test (group S), a prolonged submaximal treadmill run to exhaustion. O2 uptake, heart rate, ventilation, and perceived exertion were determined during each test. Perception of pain was assessed after exercise by use of a modified McGill pain questionnaire. No significant differences between placebo and naloxone treatments were found in any of the measured variables at the usually accepted 5% (P = 0.05) confidence level; however, evidence suggesting differences (i.e., P = 0.1 to 0.05) in these important respects was observed. In group M, maximal exercise performance measured by maximal O2 consumption was not different between placebo and naloxone; results suggest that VE was increased (P = 0.08) following naloxone, but only at the final work stage. In group S, exercise performance time was reduced following naloxone (P = 0.09), whereas the affective component of pain was increased (P = 0.06); no differences in the measured physiological variables were observed. These results suggest the following: 1) the opiate receptor-endorphin system may alter the perception of pain associated with prolonged high-intensity submaximal exercise with a resultant significant effect on performance; and 2) it may play a role in the control of ventilation during maximal exercise.

This article has been cited by other articles:

				A. L. Sgherza, K. Axen, R. Fain, R. S. Hoffman, C. C. Dunbar, and F. Haas Effect of naloxone on perceived exertion and exercise capacity during maximal cycle ergometry J Appl Physiol, December 1, 2002; 93(6): 2023 - 2028. [Abstract] [Full Text] [PDF]

				S. D. LEE, H. NAKANO, L. E. GOSSELIN, J. A. KRASNEY, E. H. SCHLENKER, and G. A. FARKAS Endogenous Opioids Modulate Ventilation and Peak Oxygen Consumption in Obese Zucker Rats Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1009 - 1015. [Abstract] [Full Text]

				D. Laurent, K. E. Schneider, W. K. Prusaczyk, C. Franklin, S. M. Vogel, M. Krssak, K. F. Petersen, H. W. Goforth, and G. I. Shulman Effects of Caffeine on Muscle Glycogen Utilization and the Neuroendocrine Axis during Exercise J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2170 - 2175. [Abstract] [Full Text]

				P. P. Manfroy, J. A. Ashton-Miller, and E. M. Wojtys The Effect of Exercise, Prewrap, and Athletic Tape on the Maximal Active and Passive Ankle Resistance to Ankle Inversion Am. J. Sports Med., March 1, 1997; 25(2): 156 - 163. [Abstract] [PDF]